Enkephalins Reduce Stress Behavior While Dynorphin Amplifies It — Opposing Opioid Systems
Enkephalins and dynorphin have opposite effects on stress behavior: enkephalins reduce anxiety-like responses while dynorphin worsens them, with selective cross-talk between the two systems.
Quick Facts
What This Study Found
Enkephalin and dynorphin systems have opposing effects on stress behavior. The dynorphin system selectively interacts with the met-enkephalin system but not the leu-enkephalin system.
Key Numbers
How They Did This
Rats received intracerebroventricular opioid peptide injections. Two behavioral tests measured stress responses: conditioned suppression of motility and forced swim immobility.
Why This Research Matters
This shows the opioid system has both stress-reducing and stress-amplifying arms. The balance between enkephalin and dynorphin signaling may determine how well an individual copes with stress.
The Bigger Picture
The balance between enkephalin and dynorphin signaling may be a key determinant of stress resilience. People with stronger enkephalin systems may cope better with stress, while dominant dynorphin signaling could predispose to anxiety and depression. This framework has influenced modern research on stress-related mental health conditions.
What This Study Doesn't Tell Us
Animal study using brain-injected synthetic analogs at pharmacological doses. Natural stress responses involve complex interactions beyond just two peptide systems.
Questions This Raises
- ?Is an imbalance between enkephalin and dynorphin signaling involved in anxiety disorders?
- ?Could enhancing enkephalin signaling or blocking dynorphin improve stress resilience?
Trust & Context
- Key Stat:
- Opposing opioid systems Enkephalins attenuated stress behaviors while dynorphin potentiated them, with selective met-enkephalin/dynorphin cross-talk
- Evidence Grade:
- Preliminary animal study using pharmacological brain injections. Demonstrates opposing effects clearly but at non-physiological doses.
- Study Age:
- Published in 1990. The opposing roles of enkephalin and dynorphin in stress and mood have been extensively validated and inform current research on kappa opioid antagonists for depression.
- Original Title:
- Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.
- Published In:
- The Journal of pharmacology and experimental therapeutics, 253(2), 600-7 (1990)
- Authors:
- Katoh, A(2), Nabeshima, T(2), Kameyama, T(3)
- Database ID:
- RPEP-00161
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why do two opioid peptides have opposite effects on stress?
Enkephalins activate delta and mu receptors, which promote feelings of well-being and resilience. Dynorphin activates kappa receptors, which are associated with dysphoria and stress amplification. The body uses both systems to calibrate stress responses.
Could this explain why some people handle stress better than others?
Possibly. Individual differences in the balance between enkephalin and dynorphin systems could influence stress resilience. People with naturally higher enkephalin activity may cope better, while those with dominant dynorphin signaling may be more vulnerable to anxiety and depression.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00161APA
Katoh, A; Nabeshima, T; Kameyama, T. (1990). Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.. The Journal of pharmacology and experimental therapeutics, 253(2), 600-7.
MLA
Katoh, A, et al. "Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.." The Journal of pharmacology and experimental therapeutics, 1990.
RethinkPeptides
RethinkPeptides Research Database. "Behavioral changes induced by stressful situations: effects ..." RPEP-00161. Retrieved from https://rethinkpeptides.com/research/katoh-1990-behavioral-changes-induced-by
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.